for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

China's CanSino says no blood clots reported from COVID-19 shot

April 14 (Reuters) - China’s CanSino Biologics Inc said on Wednesday that no serious blood clot cases related to its COVID-19 vaccine had been reported so far.

The announcement comes amid multiple cases of people being diagnosed with a blood clot after receiving COVID-19 shots made by AstraZeneca and Johnson & Johnson. (Reporting by Shashwat Awasthi in Bengaluru; Editing by Shounak Dasgupta)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up